IndraLab

Statements

Tetrathiomolybdate(2-) inhibits NLRP3. 2 / 2

| 2

reach

"A clinically approved copper chelator, tetrathiomolybdate, inhibits the canonical NLRP3 inflammasome, but not the AIM2, NLRC4, and NLRP1 inflammasomes."

38102020

➶

reach

"A clinically approved copper chelator, tetrathiomolybdate, inhibited the canonical NLRP3 but not the AIM2, NLRC4, and NLRP1 inflammasomes or NF-kappaB-dependent priming."

29358279

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Tetrathiomolybdate(2-) inhibits NLRP3. 2 / 2

INDRA sources:

Databases

Reading